Development of CaReScreen, a Digital Health Tool for Assessing Late Effects and Cancer Rehabilitation Needs in Cancer Survivors: Protocol for a Qualitative Development and Formative Design Study
Entwicklung von CaReScreen, einem digitalen Gesundheitstool zur Erfassung von Spätfolgen und Rehabilitationsbedarfen bei Krebspatient:innen: Protokoll einer qualitativen Entwicklungs- und Formativdesign-Studie
JMIR Research Protocols · 2026-10-29 · 15 · e105443-e105443
DOI: 10.2196/105443 ↗Auf einen Blick
CaReScreen wurde als digitales Tool zur systematischen Erfassung von Spätfolgen und Rehabilitationsbedarf entwickelt. Der Prototyp mit Ampelsystem ist erstellt; die Validierung läuft.
Fragestellung
Welche Ziele, welches Design und welcher Zeitplan liegen dem CaReScreen-Projekt zur Erfassung von Spätfolgen und Rehabilitationsbedarf bei Krebsüberlebenden zugrunde?
Methode
Iterative, qualitative und partizipative Entwicklung; 40 Interviews (9 Gruppen-, 31 Einzelinterviews) mit 72 Informant:innen in Norwegen. Auswahl des Instruments: EORTC QLQ-SURV100 plus 5 EORTC QLQ-C30 Items.
Ergebnisse
Ein erster Prototyp wurde mit Gesundheitsfachpersonen und Krebsüberlebenden entwickelt. Er zeigt multidimensionale Bedürfnisse digital und nutzt ein Ampelsystem: grün, gelb, rot. Die Validierung läuft; 800 Teilnehmende sind eingeschlossen.
Einschränkungen
Die Ergebnisse der laufenden Validierung und der geplanten Machbarkeitsstudie werden in diesem Artikel nicht berichtet.
Schlussfolgerung der Autor:innen
Das Team hat einen ersten digitalen Prototyp entwickelt, um Spätfolgen, Funktion und unerfüllte Rehabilitationsbedarfe systematisch zu erfassen. Der Prototyp soll nun validiert und auf Machbarkeit geprüft werden.
Kernaussagen
- Prototyp mit digitalem Bericht und Ampelsystem entwickelt
- 40 Interviews mit 72 Informant:innen informierten die Entwicklung
- Validierung läuft; 800 Teilnehmende bisher eingeschlossen
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
At a glance
Studienprotokoll in JMIR Research Protocols, published online on 2026-10-29. Written by Maja Kulosman and 7 co-authors. Institution: Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, P.O. 8905, Tr…. Major MEDLINE topics: Cancer Survivors, Neoplasms. 36 references. The full text is freely available in PubMed Central.
Topics: Digitalisierung in der Pflege
Abstract (original language)
Background
Due to advances in cancer diagnostics and treatments, life expectancy after cancer and the number of cancer survivors are increasing. Symptoms and late effects frequently occur in cancer survivors, with a negative impact on functioning and participation in society. Digital health tools might be helpful to systematically assess symptom burden of late effects and rehabilitation needs.
Objective
This paper describes the objectives, design, and current status of the Cancer Rehabilitation Screening (CaReScreen) project. The aims are (1) to report the completed development phase of the digital health tool CaReScreen, comprising the exploratory work, the establishment of the interdisciplinary team, the selection of the assessment instrument, and the development of the initial prototype, and (2) to define the objectives, design, and timelines of the ongoing validation of the scoring manual and of the planned large-scale feasibility study.
Methods
Development followed an iterative, qualitative, and participatory design approach guided by established frameworks for digital health development. It was informed by exploratory qualitative work comprising 40 interviews (9 group and 31 individual) involving 72 informants across Norway, which identified systematic assessment of late effects and navigation of rehabilitation services as the primary unmet needs in cancer survivorship follow-up. A 105-item patient-reported outcome measure (European Organization for Research and Treatment of Cancer [EORTC] QLQ-SURV100, supplemented with 5 EORTC QLQ-C30 items) was selected as the main assessment instrument. This paper reports the completed development phase; the ongoing validation study and the planned feasibility study are described in terms of objectives, design, and timelines, but their results are not reported here.
Results
An initial prototype was developed with health care professionals and cancer survivors as intended end users. It consists of a digital report that identifies and graphically visualizes a panoramic view of multidimensional needs, based on a traffic light scoring system: green indicates low symptom burden and high functioning, yellow moderate symptom burden and moderate functioning, and red high symptom burden and low functioning. The project is funded for the period 2022 to 2028. The development phase is completed, as well as early prototype usability and usefulness testing. Validation of the scoring manual is ongoing, with 800 participants included to date and reporting expected in spring 2027. A large-scale feasibility study is planned to commence in 2027.
Conclusions
The CaReScreen interdisciplinary team has developed an initial digital health tool prototype with the main aim of enabling systematic assessment of late effects, functioning, and unmet rehabilitation needs in cancer survivors. The prototype now proceeds to validation and feasibility testing, which will determine its clinical utility and support regulatory approval under the European Medical Device Regulation.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, P.O. 8905, Trondheim, Trøndelag, 7491, Norway, 47 72853114.
- Cancer Clinic, St Olav's University Hospital, Trondheim, Trøndelag, Norway.
- Unicare, Oslo, Norway.
- Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.
- Department of Health Services Research, SINTEF Digital, Trondheim, Trøndelag, Norway.
- Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Trøndelag, Norway.
Cite
APA
Kulosman, M., Engan, H. K., Fagerli, U. M., Reinertsen, K. V., Sand, K., Sandmæl, J. A., Solberg, A., & Tandstad, T. (2026). Development of CaReScreen, a Digital Health Tool for Assessing Late Effects and Cancer Rehabilitation Needs in Cancer Survivors: Protocol for a Qualitative Development and Formative Design Study. JMIR Research Protocols, 15, e105443-e105443. https://doi.org/10.2196/105443
Vancouver
Kulosman M, Engan HK, Fagerli UM, Reinertsen KV, Sand K, Sandmæl JA, et al. Development of CaReScreen, a Digital Health Tool for Assessing Late Effects and Cancer Rehabilitation Needs in Cancer Survivors: Protocol for a Qualitative Development and Formative Design Study. JMIR Research Protocols. 2026;15:e105443-e105443. doi:10.2196/105443
BibTeX
@article{Kulosman2026,
author = {Kulosman, Maja and Engan, Harald Kåre and Fagerli, Unn Merete and Reinertsen, Kristin Valborg and Sand, Kari and Sandmæl, Jon Arne and Solberg, Arne and Tandstad, Torgrim},
title = {Development of CaReScreen, a Digital Health Tool for Assessing Late Effects and Cancer Rehabilitation Needs in Cancer Survivors: Protocol for a Qualitative Development and Formative Design Study},
journal = {JMIR Research Protocols},
year = {2026},
volume = {15},
pages = {e105443--e105443},
doi = {10.2196/105443}
}
EUVIMED